Prelude Capital Management’s Sanaby Health Acquisition Corp. I Unit SANBU Stock Holding History

Prelude Capital Management’s Portfolio SANBU Stock Details SANBU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-53,900	Closed	-$541K	–	2143
2022 Q2	$541K	Hold	53,900	–	–	0.02%	778
2022 Q1	$543K	Sell	53,900 -2,900	-5%	-$29.4K	0.02%	823
2021 Q4	$576K	Buy	+56,800	New	+$576K	0.01%	929

Other funds holding SANBU

SFM

Spartan Fund Management Toronto, Ontario, Canada $30M AUM 11.98% 1-Year Est. Return

Walleye Capital New York $24B AUM 37.67% 1-Year Est. Return

YCM

Yakira Capital Management Westport, Connecticut $342M AUM 26.97% 1-Year Est. Return

WAM

Wolverine Asset Management Chicago, Illinois $10.4B AUM 4.78% 1-Year Est. Return

SSA

Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return

Clear Street New York $24.6B AUM 56.26% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Prelude Capital Management's SANBU Position: Q3 2022 in Review

Prelude Capital Management sold out of Sanaby Health Acquisition Corp. I Unit (SANBU) in Q3 2022, closing a stake of 53,900 shares — an estimated $541K sold.

Prelude Capital Management first reported a position in SANBU in Q4 2021 and held it in 3 quarters. The position peaked at $576K in Q4 2021. 8 funds tracked by Wall St. Rank hold SANBU as of Q3 2022.

Prelude Capital Management reported no remaining Sanaby Health Acquisition Corp. I Unit position as of Q3 2022 after selling out during the quarter.
Prelude Capital Management sold 53,900 Sanaby Health Acquisition Corp. I Unit shares in Q3 2022, an estimated $541K.
Prelude Capital Management first reported a position in Sanaby Health Acquisition Corp. I Unit in Q4 2021 and held it in 3 quarters.
Prelude Capital Management's Sanaby Health Acquisition Corp. I Unit position peaked at $576K in Q4 2021.
8 funds tracked by Wall St. Rank held Sanaby Health Acquisition Corp. I Unit as of Q3 2022.

Based on Prelude Capital Management's 13F filing for Q3 2022, filed 14 Nov 2022.